Ultima-Aromasin 25

Manufacturer: Ultima Pharmaceuticals

Pharmaceutical name: Exemestane

Pack: 1 pack (50 tabs (25 mg))

Ultima-Aromasin 25 is a next-generation medication that inhibits the enzymes responsible for aromatization. Exemestane stands apart from other drugs in the aromatase inhibitor category. Ultima-Aromasin 25 offers superior efficacy. Unlike conventional aromatase inhibitors that provide only temporary relief, Ultima-Aromasin 25 delivers an irreversible and lasting impact. This medication suppresses estrogens in an athlete's body by 85% or more.

 

While on a steroid cycle, Ultima-Aromasin 25 helps mitigate the side effects associated with steroid use, specifically aromatization. It's important to highlight that the action of Ultima-Aromasin 25 is fundamentally different from Nolvadex, which many athletes are familiar with. Tamoxifen is known for not affecting the aromatization process; rather, it binds to the cellular estrogen receptors, blocking estrogen from attaching and forming a connection. In contrast, exemestane specifically targets and suppresses aromatization. The structure of Ultima-Aromasin 25 closely resembles that of the naturally occurring steroid androstenedione. Exemestane works by irreversibly attaching to the active hormone enzymes, rendering them inactive. Ultima-Aromasin 25 does not possess estrogenic or progestogenic properties but exhibits mild androgenic activity.

 

It is indicated for treating breast cancer in postmenopausal women (whether naturally or artificially induced) that progresses despite antiestrogen therapy, non-steroidal aromatase inhibitors, or progestins.

 

The recommended dosage for men is 12.5-25 mg/day, while for women it is 12.5 mg/day.

 

Ultima-Aromasin 25 may lead to side effects that can vary in intensity. Athletes might experience adverse effects such as nausea, fatigue, sweating, dizziness, headaches, skin rashes, insomnia, and others.